AbbVie ABBV
NYSE ABBV
$262.21 -1.08 (-0.41%)
As of: Sep 30, 2026 · 3:59 PM EDT

AbbVie (ABBV) Total Current Liabilities (2012 - 2026)

Updated

AbbVie (ABBV) posted Total Current Liabilities of $41.64 billion for Q2 2026, up 4.7% from $39.77 billion a year earlier but down 1.1% from the prior quarter.

Analysis

AbbVie (ABBV) Total Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie's Total Current Liabilities came in at $43.29 billion, up 11.7% from FY2024.

  • Annual Total Current Liabilities has increased for three consecutive years, with a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • In prior years, AbbVie's Total Current Liabilities was $38.75 billion in FY2024 (+2.4%), $37.84 billion in FY2023 (+28.1%), $29.54 billion in FY2022 (-16.1%) and $35.19 billion in FY2021 (+22.8%).
  • Quarterly Total Current Liabilities has run from a low of $27.59 billion in Q1 2023 to a high of $43.29 billion in Q4 2025 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 4.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2024, with growth of 50.5%; the weakest was Q4 2022, with a decline of 16.1%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $42.1 billion (Q1 2026), $43.29 billion (Q4 2025) and $39.39 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 18.66 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.64 Bn
Mar 31, 2026 42.10 Bn
Dec 31, 2025 43.29 Bn
Sep 30, 2025 39.39 Bn
Jun 30, 2025 39.77 Bn
Mar 31, 2025 36.40 Bn
Dec 31, 2024 38.75 Bn
Sep 30, 2024 43.06 Bn
Jun 30, 2024 41.92 Bn
Mar 31, 2024 41.52 Bn
Dec 31, 2023 37.84 Bn
Sep 30, 2023 34.77 Bn
Jun 30, 2023 32.24 Bn
Mar 31, 2023 27.59 Bn
Dec 31, 2022 29.54 Bn
Sep 30, 2022 32.71 Bn
Jun 30, 2022 34.47 Bn
Mar 31, 2022 32.52 Bn
Dec 31, 2021 35.19 Bn
Sep 30, 2021 28.53 Bn
API Access

AbbVie Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY